Expert Consensus on the Diagnosis and Treatment of Anticancer Drug-Induced Interstitial Lung Disease

Drug-induced interstitial lung disease (DILD) is the most common pulmonary adverse event of anticancer drugs. In recent years, the incidence of anticancer DILD has gradually increased with the rapid development of novel anticancer agents. Due to the diverse clinical manifestations and the lack of sp...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Hua-ping, Ma, Fei, Ren, Yan-hong, Chen, Shan-shan, Li, Yi-qun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Huazhong University of Science and Technology 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982790/
https://www.ncbi.nlm.nih.gov/pubmed/36867358
http://dx.doi.org/10.1007/s11596-022-2693-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9982790/
https://www.ncbi.nlm.nih.gov/pubmed/36867358
http://dx.doi.org/10.1007/s11596-022-2693-2

Ejemplares similares